BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 25, 2006
View Archived Issues
Sirna Brings In $45M Publicly; Lead Drug Aimed For Phase II
Sirna Therapeutics Inc. bolstered its bank account with a $45 million financing that closed Wednesday. (BioWorld Today)
Read More
CareX Purchase Expands 7TM's Early Stage Metabolic Pipeline
Read More
Ocera's AST-120 In Phase III Trial For Fistulizing Crohn's
Read More
Aphton Bankruptcy News Blasts Stock; Igeneon Also Facing Risk
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
Clinic Roundup
Read More